US EditionTrump calls on pharmaceutical companies to justify success of COVID drugs
President Trump calls for pharmaceutical companies to publicly justify COVID-19 vaccine success amid CDC leadership upheaval and policy changes led by Health Secretary Robert F. Kennedy Jr.
- President Donald Trump called on pharmaceutical companies, including Pfizer, to disclose evidence about the effectiveness of their COVID-19 treatments, emphasizing the need for transparency.
- Trump has seen extraordinary data from Pfizer that has not been made public and urged them to share these results.
- His remarks followed the dismissal of CDC Director Susan Monarez and other officials, amid criticism of public health decisions.
- Public health experts, including Jennifer Nuzzo, have defended the effectiveness of COVID-19 vaccines.
112 Articles
112 Articles
‘Clear up this mess’: Trump demands companies justify the success of their COVID drugs
'Clear up this mess': Trump demands companies justify the success of their COVID drugs · American Wire News
President Donald Trump on Monday demanded that the big pharmaceutical giants “justify” the success of their COVID vaccines. “It is very important that the Drug Companies justify the success of their various COVID Drugs,” he wrote in a post published to Truth Social. “Many people think they are a miracle that saved Millions of lives. Others disagree! With CDC being ripped apart over this question, I want the answer, and I want it NOW,” he continu…
President Trump Demands Big Pharma Justify COVID Vaccine Success
You know the feeling, don’t you? It’s that little voice in your head that’s been telling you something isn’t right. It started a few years... The post President Trump Demands Big Pharma Justify COVID Vaccine Success appeared first on Patriot Journal.
Trump demands Pfizer prove mRNA jabs work: "I want the answer"
Late last month a CDC advisory committee launched a review into the "safety, effectiveness, and immunogenicity" of COVID-19 vaccines, as well as whether mRNA remains in the body longer than advertised. As part of the review, they will look at gaps in existing knowledge "relating to bio distribution, pharmacokinetics, and persistence of the spike protein, mRNA, and lipid nanoparticles to inform immunization recommendations," the document states. …
Coverage Details
Bias Distribution
- 51% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
